Trial intelligence / Profile preview

Propranolol effects on trigeminally induced dermal blood flow in healthy volunteers

NL-OMON20883Not yet recruiting

Sponsor
Erasmus MC
Start
Mar 2016
Modality
Small Molecules
Countries
1
01

Overview

Trial of propranolol in migraine (2 arms), sponsored by Erasmus MC. Primary endpoint: Change in forehead dermal blood flow. Planned start Mar 2016; status: not yet recruiting.

02

Drugs

propranolol
03

Conditions

migraine

Beyond the preview

Go deeper on NL-OMON20883.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NL-OMON20883.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call